Obstetrics/Gynecology
RSSArticles
-
Conservatives Work to Bar Private Coverage of Abortion
-
Safety Warning Issued for Fluoroquinolone Antibiotics
The federal Food and Drug Administration (FDA) now is asking clinicians to consider other treatment options besides fluoroquinolone antibiotics because of risks associated with their use.
-
More Teens Are Up to Date on HPV Shot
Just-released data indicate human papillomavirus (HPV) vaccination completion in U.S. adolescents increased by five percentage points from 2016 to 2017, and initiation of the vaccine has gone up 5.1 percentage points, on average, each year since 2013.
-
Barriers Still Exist for Teen Access to Emergency Contraception
Even though age limits for purchasing emergency contraception (EC) were removed five years ago, results of a recent survey of more than 700 Texas pharmacies found that 46.5% of drugstores still have an age restriction for buying the medication, and more than 50% require a consultation before medication purchase.
-
USPSTF Issues Final Guidance for Cervical Cancer Screening
The US Preventive Services Task Force has issued final recommendations for cervical cancer screening, calling for women ages 21 to 29 to be tested with cervical cytology every three years.
-
Does Every Woman Deserve a High-volume Gynecologic Surgeon?
Generally, gynecologic surgical complications are higher with lower-volume surgeons.
-
Vaginal Progesterone vs. Cerclage to Prevent Preterm Birth
SYNOPSIS: A recent indirect comparison meta-analysis has shown that vaginal progesterone is as useful in decreasing preterm birth and its associated adverse outcomes as cervical cerclage in patients with a history of preterm birth and short cervices.
-
Intrauterine Devices and Cervical Cancer
In this case-control study, levonorgestrel IUD use was associated with a slightly increased rate of CIN 2 but not CIN 3. Copper IUD use was not associated with CIN 2 or CIN 3.
-
Primary HPV Screening: Ready for Prime Time?
In this randomized, controlled trial of more than 25,000 women, participants with negative high-risk human papillomavirus testing at baseline had rates of CIN 3+ at 48 months that were lower compared to negative liquid-based cytology testing.
-
USPSTF Recommendation: Screening for Cervical Cancer
The U.S. Preventive Services Task Force (USPSTF) recently updated its recommendations for cervical cancer screening. Practitioners currently following guidelines published by ASCCP (and supported by ACOG) will not find any discrepancies in the new USPSTF position